arrow
W

Weiqiang Zhou

Shenyang Medical College
H指数:24
被引数:1,598

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1

人胰腺癌异种移植物的CRISPR筛选通过表观遗传修饰剂NCAPD2和MTHFD1鉴定KLF5增殖脆弱性

2026-02-100
OAAI
SARS-CoV-2 induces neutrophil degranulation and differentiation into myeloid-derived suppressor cells associated with severe COVID-19

SARS-CoV-2诱导中性粒细胞脱颗粒并分化为髓源性抑制细胞,这与重症COVID-19相关。

2025-05-210
PRE
Multipronged SMAD pathway targeting by lipophilic poly(β-amino ester) miR-590-3p nanomiRs inhibits mesenchymal glioblastoma growth and prolongs survival

脂溶性聚(β-氨基酯) miR-590-3p 纳米miR通过多靶点SMAD通路靶向抑制间充质胶质母细胞瘤生长并延长生存期

2025-04-300
OA
DNA methylation memory of pancreatic acinar-ductal metaplasia transition state altering Kras-downstream PI3K and Rho GTPase signaling in the absence of Kras mutation

DNA甲基化记忆调控胰腺腺泡-导管上皮化生转换状态,该过程在缺乏Kras突变的情况下改变了Kras下游的PI3K和Rho GTPase信号通路。

2025-03-280
OA
Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer

SMYD2对染色质修饰因子KMT2D的甲基化有助于激素依赖性乳腺癌的治疗反应

2024-05-011
OAAI
Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients
2022-09-014
OA
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function
2021-11-2617
OAAI